9.98
price down icon1.48%   -0.15
after-market Handel nachbörslich: 9.98
loading
Schlusskurs vom Vortag:
$10.13
Offen:
$10.16
24-Stunden-Volumen:
1.78M
Relative Volume:
1.07
Marktkapitalisierung:
$1.17B
Einnahmen:
$260.81M
Nettoeinkommen (Verlust:
$20.48M
KGV:
76.77
EPS:
0.13
Netto-Cashflow:
$22.67M
1W Leistung:
-2.82%
1M Leistung:
-10.41%
6M Leistung:
-28.10%
1J Leistung:
-8.10%
1-Tages-Spanne:
Value
$9.90
$10.28
1-Wochen-Bereich:
Value
$9.77
$10.30
52-Wochen-Spanne:
Value
$9.22
$14.63

Dynavax Technologies Corp Stock (DVAX) Company Profile

Name
Firmenname
Dynavax Technologies Corp
Name
Telefon
(510) 848-5100
Name
Adresse
2100 POWELL STREET, EMERYVILLE, CA
Name
Mitarbeiter
405
Name
Twitter
@DynavaxCorp
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
DVAX's Discussions on Twitter

Vergleichen Sie DVAX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
DVAX
Dynavax Technologies Corp
9.98 1.16B 260.81M 20.48M 22.67M 0.13
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.20 67.75B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.29 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.84 43.70B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.48 21.51B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
380.47 18.31B 2.99B 1.21B 1.13B 25.06

Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-11 Herabstufung Goldman Neutral → Sell
2024-02-01 Eingeleitet Goldman Neutral
2022-09-27 Eingeleitet JMP Securities Mkt Outperform
2022-01-06 Fortgesetzt Goldman Buy
2021-08-06 Eingeleitet Goldman Buy
2020-08-07 Bestätigt H.C. Wainwright Buy
2020-08-03 Bestätigt H.C. Wainwright Buy
2020-06-15 Eingeleitet Evercore ISI Outperform
2019-10-18 Eingeleitet H.C. Wainwright Buy
2019-07-11 Hochstufung Cantor Fitzgerald Neutral → Overweight
2019-02-27 Bestätigt Cantor Fitzgerald Overweight
2018-05-10 Hochstufung JP Morgan Neutral → Overweight
2018-03-08 Bestätigt Cantor Fitzgerald Overweight
2018-02-14 Herabstufung JP Morgan Overweight → Neutral
2017-09-25 Bestätigt RBC Capital Mkts Outperform
2017-09-15 Eingeleitet Cantor Fitzgerald Overweight
2017-07-31 Hochstufung JP Morgan Neutral → Overweight
2017-07-31 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2017-05-09 Bestätigt RBC Capital Mkts Sector Perform
2016-04-28 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2016-04-27 Herabstufung JP Morgan Overweight → Neutral
2015-11-30 Eingeleitet RBC Capital Mkts Outperform
2013-11-25 Hochstufung MLV & Co Hold → Buy
2013-02-25 Herabstufung MLV & Co Buy → Hold
2012-11-16 Bestätigt MLV & Co Buy
Alle ansehen

Dynavax Technologies Corp Aktie (DVAX) Neueste Nachrichten

pulisher
Sep 03, 2025

Applying sector rotation models to Dynavax Technologies CorporationJuly 2025 Market Mood & Real-Time Chart Pattern Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Top chart patterns to watch in Dynavax Technologies CorporationJuly 2025 Review & Risk Controlled Swing Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can machine learning forecast Dynavax Technologies Corporation recoveryMarket Trend Summary & Daily Momentum Trading Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Applying Wyckoff theory to Dynavax Technologies Corporation stockMarket Performance Report & Free Fast Entry Momentum Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What the charts say about Dynavax Technologies Corporation today2025 Winners & Losers & Real-Time Volume Trigger Notifications - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Multi asset correlation models including Dynavax Technologies CorporationJuly 2025 Intraday Action & Daily Entry Point Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Intraday pattern recognizer results for Dynavax Technologies CorporationJuly 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Dynavax Technologies Corporation stock entering bullish territoryMarket Weekly Review & Low Volatility Stock Suggestions - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Price action breakdown for Dynavax Technologies CorporationExit Point & AI Driven Stock Movement Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Dynavax Technologies Corporation stock trendline breakdownQuarterly Profit Review & Community Verified Watchlist Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Visual trend scoring systems applied to Dynavax Technologies CorporationMarket Trend Report & High Return Trade Guides - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Wellington Management Group LLP Has $736,000 Holdings in Dynavax Technologies Corporation $DVAX - Defense World

Sep 02, 2025
pulisher
Sep 02, 2025

Northern Trust Corp Cuts Stock Holdings in Dynavax Technologies Corporation $DVAX - Defense World

Sep 02, 2025
pulisher
Sep 02, 2025

HighTower Advisors LLC Has $365,000 Position in Dynavax Technologies Corporation $DVAX - Defense World

Sep 02, 2025
pulisher
Sep 02, 2025

Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook - Insider Monkey

Sep 02, 2025
pulisher
Sep 02, 2025

Dynavax’s SWOT analysis: vaccine maker’s stock poised for growth amid challenges - Investing.com

Sep 02, 2025
pulisher
Sep 02, 2025

Visual analytics tools that track Dynavax Technologies Corporation performanceWeekly Trade Summary & Community Consensus Picks - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

What recovery options are there for Dynavax Technologies CorporationWeekly Trend Summary & Community Supported Trade Ideas - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Dynavax Technologies Corporation stock volume spike explainedPortfolio Update Report & Long-Term Safe Investment Plans - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Signal strength of Dynavax Technologies Corporation stock in tech scannersPortfolio Value Report & Verified Short-Term Trading Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using Python tools to backtest Dynavax Technologies Corporation strategiesJuly 2025 Closing Moves & Technical Pattern Based Buy Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

When is the best time to exit Dynavax Technologies CorporationJuly 2025 Gainers & Technical Pattern Based Buy Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will Dynavax Technologies Corporation benefit from macro trendsMarket Trend Review & Free Real-Time Volume Trigger Notifications - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Dynavax Technologies Corporation stock retracement – recovery analysisTrade Analysis Report & Expert-Curated Trade Recommendations - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What data driven models say about Dynavax Technologies Corporation’s futureMarket Sentiment Report & AI Forecast Swing Trade Picks - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Pattern recognition hints at Dynavax Technologies Corporation upsideTrade Signal Summary & Safe Capital Allocation Plans - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

What earnings revisions data tells us about Dynavax Technologies CorporationMarket Volume Report & Weekly Chart Analysis and Trade Guides - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Has Dynavax Technologies Corporation formed a bullish divergenceWeekly Gains Summary & Scalable Portfolio Growth Methods - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Analyzing drawdowns of Dynavax Technologies Corporation with statistical toolsRecession Risk & Consistent Growth Stock Picks - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Statistical indicators supporting Dynavax Technologies Corporation’s strength2025 Sector Review & Real-Time Buy Signal Notifications - Newser

Aug 29, 2025

Finanzdaten der Dynavax Technologies Corp-Aktie (DVAX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Dynavax Technologies Corp-Aktie (DVAX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Deep Track Biotechnology Maste
10% Owner
Aug 21 '25
Sale
11.03
1,094,994
12,077,784
16,696,492
Deep Track Biotechnology Maste
10% Owner
Aug 22 '25
Sale
10.59
970,143
10,273,814
15,726,349
Novack David F
President & COO
Mar 24 '25
Option Exercise
6.80
10,000
68,050
18,078
Novack David F
President & COO
Mar 24 '25
Sale
14.00
10,000
140,000
8,078
$28.92
price down icon 3.60%
$17.47
price up icon 0.69%
drug_manufacturers_specialty_generic RDY
$14.15
price down icon 0.28%
$10.33
price down icon 2.09%
$140.40
price up icon 3.15%
$380.47
price down icon 2.80%
Kapitalisierung:     |  Volumen (24h):